Regional bank fears return
Wall Street Breakfast
00:00
Merck's Cancer Therapy Results, PlugPower's Liquid Green Hydrogen, and Stock Market Predictions
This chapter discusses the sales performance of Merck's cancer therapy drug, K-Truda, and the achievement of PlugPower in producing liquid green hydrogen. It also includes insights on the correlation between positive January returns in the stock market and a higher market performance for the rest of the year.
Play episode from 04:27
Transcript
